NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Advanced Micro (AMD) downgraded at Citigroup from Buy to Neutral, Citigroup said. Estimates also cut, following negative checks in Asia.
Abercrombie & Fitch (ANF) rated new Sell at Citigroup. $32 price target. Company's fashion trends are lagging.
Cliffs Natural (CLF) upgraded at Nomura to Buy, Nomura said. $54 price target. Iron ore prices may be at an inflection point.Darden (DRI) downgraded at Baird from Outperform to Neutral, Robert Baird said. $58 price target. Valuation call, as the stock is up 23% year-to-date. Cabot Microelectronics (CCMP) upgraded to buy at TheStreet Ratings. Electronics for Imaging (EFII) upgraded to buy at TheStreet Ratings. Foster Wheeler (FWLT) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $30 price target. Seeing a cyclical recovery in the overall E&C market. Haemonetics (HAE) rated new Buy at Benchmark. $89 price target. Company can leverage its steady organic revenue growth. Intel (INTC - Get Report) downgraded at Citigroup from Buy to Neutral, Citigroup said. Company cut guidance and the PC market will likely remain soft. Limited (LTD) rated new Buy at Citigroup. $60 price target. Company is managing inventory well and growing in non-apparel categories. Magnum Hunter (MHR) rated new Outperform at Credit Suisse. $6 price target. Company can deliver solid growth through 2014. Marvell Technology (MRVL) downgraded at Citigroup from Buy to Neutral, Citigroup said. Chip sector lacks near-term catalysts. Nike (NKE - Get Report) downgraded at Citigroup from Buy to Neutral, Citigroup said. Valuation call, based on a $101 price target. Northrop Grumman (NOC - Get Report) downgraded at UBS from Neutral to Sell, UBS said. Valuation call, based on a $64 price target. AT&T (T - Get Report) downgraded at Hudson Square from Buy to Hold, Hudson Square said. Valuation call, as marginal will be difficult to find from current levels. TJX (TJX) rated new Buy at Citigroup. $55 price target. Company can continue to expand its operating margin. T. Rowe Price (TROW) downgraded at Credit Suisse to Neutral from Outperform, Credit Suisse said. $66 price target. Costs are rising and the company is seeing lower institutional flows.